PATENT CLAIM ANALYSIS

Application Number: 16186772
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "094000"]

Abstract:
Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.

Claim (Index 4):
A crystalline form of zoledronic acid according to  claim 2 , wherein the crystalline form is a hydrate.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 98.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13826691', '13567827', '15288139', '15819191', '15609641']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8371515053186375
- 35 USC 102 Novelty (BERT): 0.5944596476253226
- Combined Prediction Score: 0.812882319549306
- Mean Citation Score: 522.3449840000002
- Max Citation Score: 556.95844
- Similarity Product: 411.8675053418468

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test